|
|
| Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
| Bank Loan Ratings | 27.09 | ACUITE D | Reaffirmed | Issuer not co-operating* | - |
| Bank Loan Ratings | 0.80 | - | ACUITE D | Reaffirmed | Issuer not co-operating* |
| Total Outstanding | 27.89 | - | - |
| Total Withdrawn | 0.00 | - | - |
| * The issuer did not co-operate; based on best available information. | |||
|
Rating Rationale |
|
Acuité has reaffirmed the long-term rating of ‘ACUITE D’ (read as ACUITE D) and short-term rating of ‘ACUITE D’ (read as ACUITE D) on the Rs. 27.89 crore bank facilities of J S Medimax Private Limited (JSMPL). The rating continues to be flagged as “Issuer Not Cooperating” and is based on the best available information |
| About the Company |
|
J S Medimax Private Limited incorporated in 2010, is a Delhi based company promoted by Mr. Jitender Nalwa, Mr. Tushar Tomar & Mr. Rishabh Mittal. The company is engaged in the manufacturing and trading of Orthopedic Implants, Prostheses and other Surgical Instruments. The company has tie-ups with different hospitals and clinics in the city and in north India for supply of its product. |
| Unsupported Rating |
|
Not Applicable |
| Non-cooperation by the issuer/borrower: |
|
Acuité has been requesting for data, information and undertakings from the rated entity for conducting surveillance & review of the rating. However, the issuer/borrower failed to submit such information before the due date. |
| Limitation regarding information availability: |
|
The rating is based on information available from sources other than the issuer/borrower (in the absence of information provided by the issuer/borrower). Acuité endeavored to gather information about the entity/industry from the public domain. Therefore, Acuité cautions lenders and investors regarding the use of such information, on which the indicative credit rating is based. |
| Rating Sensitivity |
|
"No information provided by the issuer / available for Acuite to comment upon." |
| Liquidity Position |
|
"No information provided by the issuer / available for Acuite to comment upon." |
| Outlook |
|
Not Applicable |
| Other Factors affecting Rating |
|
None |
| Particulars | Unit | FY 20 (Actual) | FY 19 (Actual) |
| Operating Income | Rs. Cr. | 0.61 | 0.32 |
| PAT | Rs. Cr. | (10.33) | (6.55) |
| PAT Margin | (%) | (1697.87) | (2053.26) |
| Total Debt/Tangible Net Worth | Times | (2.86) | (7.52) |
| PBDIT/Interest | Times | (1.01) | (0.10) |
| Status of non-cooperation with previous CRA |
|
Not Applicable |
| Any other information |
|
None |
| Applicable Criteria |
|
• Manufacturing Entities: https://www.acuite.in/view-rating-criteria-59.htm • Trading Entities: https://www.acuite.in/view-rating-criteria-61.htm • Default Recognition: https://www.acuite.in/view-rating-criteria-52.htm • Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm |
| Note on complexity levels of the rated instrument |
|
|||||||||||||||||||||||||||||||||||||||||||||||||
| |
|
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
| * The issuer did not co-operate; based on best available information. | ||||||||||||||||||||||||||||||||||||
|
Contacts |
About Acuité Ratings & Research |
| © Acuité Ratings & Research Limited. All Rights Reserved. | www.acuite.in |
